VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

Teri E. Klein · New England Journal of Medicine · 2009 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of <i>VKORC1</i> Haplotypes on Transcriptional Regulation and Warfarin Dose

Mark J. Rieder, Alex P. Reiner, Brian F. Gage et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Simone Rost, Andreas Fregin, Vytautas Ivaškevičius et al. · Nature · 2004 · 1.1K citations

Medicine, Genetics, Molecular Genetics +12

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

Elizabeth Sconce, Tayyaba Khan, Hilary Wynne et al. · Blood · 2005 · 947 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

Charles Eby, JA Johnson, Elena Deych et al. · Clinical Pharmacology & Therapeutics · 2008 · 834 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13